Literature DB >> 7969081

Functional cytochrome P4503A isoforms in human embryonic tissues: expression during organogenesis.

H Y Yang1, Q P Lee, A E Rettie, M R Juchau.   

Abstract

Expression of functional cytochrome P450 (CYP) isoforms in human embryonic tissues was explored during organogenesis (days 50-60 of gestation) with substrate probes, inhibitor probes, and immunoprobes and by reverse transcription-polymerase chain reaction (PCR), cloning, and sequencing. Evidence was obtained for the presence of relatively high levels of one or more functional CYP3A isoforms in embryonic livers. This was manifested as relatively extensive hydroxylation of (R)-warfarin at carbon 10 and as triacetyloleandomycin-inhibited O-debenzylation of benzyloxyresorufin when human embryonic hepatic microsomal fractions were used as enzyme sources. Immunoblots with anti-CYP3A4 antibody exhibited a strong signal in embryonic hepatic tissues but, in contrast, indicated very low or negligible CYP3A levels in human embryonic lung, kidney, heart, adrenal, and brain tissues. To explore expression of individual members of the CYP3A subfamily in human embryonic hepatic tissues at this early gestational stage, CYP3A cDNA was generated by reverse transcription, amplified by PCR, cloned, and sequenced. Oligonucleotide primers used for PCR were designed to flank target sequences unique to CYP3A but also common to all human CYP3A subfamily members for which GenBank nucleotide sequence information was available (CYP3A3, CYP3A4, CYP3A5, CYP3A5P, and CYP3A7). Sequencing data indicated that plasmids in 58 of 59 recombinant positive colonies contained an insert with a sequence identical to that present in CYP3A7 cDNA and the plasmid of only one colony contained an insert with a sequence identical to that present in CYP3A5 cDNA. No evidence was found for expression of CYP3A3 or CYP3A4. Thus, during organogenesis, human embryonic hepatic tissues express primarily CYP3A7 and are capable of significant CYP3A7-catalyzed xenobiotic monooxygenation during this very early stage of gestation.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 7969081

Source DB:  PubMed          Journal:  Mol Pharmacol        ISSN: 0026-895X            Impact factor:   4.436


  9 in total

1.  Identification of CYP3A7 for glyburide metabolism in human fetal livers.

Authors:  Diana L Shuster; Linda J Risler; Bhagwat Prasad; Justina C Calamia; Jenna L Voellinger; Edward J Kelly; Jashvant D Unadkat; Mary F Hebert; Danny D Shen; Kenneth E Thummel; Qingcheng Mao
Journal:  Biochem Pharmacol       Date:  2014-10-22       Impact factor: 5.858

Review 2.  Cytochrome P450 3A: ontogeny and drug disposition.

Authors:  S N de Wildt; G L Kearns; J S Leeder; J N van den Anker
Journal:  Clin Pharmacokinet       Date:  1999-12       Impact factor: 6.447

Review 3.  Neonatal cytochrome P450 CYP3A7: A comprehensive review of its role in development, disease, and xenobiotic metabolism.

Authors:  Haixing Li; Jed N Lampe
Journal:  Arch Biochem Biophys       Date:  2019-08-22       Impact factor: 4.013

4.  CYP3A5 and CYP3A7 genetic polymorphisms affect tacrolimus concentration in pediatric patients with nephrotic range proteinuria.

Authors:  Hongxia Liu; Qinxia Xu; Wenyan Huang; Qi Zhao; Zhihu Jiang; Xinyu Kuang; Zhiling Li; Huajun Sun; Xiaoyan Qiu
Journal:  Eur J Clin Pharmacol       Date:  2019-08-10       Impact factor: 2.953

5.  Cytochrome P450 3A and 2B6 in the developing kidney: implications for ifosfamide nephrotoxicity.

Authors:  Katarina Aleksa; Doug Matsell; Kris Krausz; Harry Gelboin; Shinya Ito; Gideon Koren
Journal:  Pediatr Nephrol       Date:  2005-05-04       Impact factor: 3.714

Review 6.  Developmental changes in the expression and function of cytochrome P450 3A isoforms: evidence from in vitro and in vivo investigations.

Authors:  Ibrahim Ince; Catherijne A J Knibbe; Meindert Danhof; Saskia N de Wildt
Journal:  Clin Pharmacokinet       Date:  2013-05       Impact factor: 6.447

7.  Metronidazole Metabolism in Neonates and the Interplay Between Ontogeny and Genetic Variation.

Authors:  Laura A Wang; Daniel Gonzalez; J Steven Leeder; Rachel F Tyndale; Robin E Pearce; Daniel K Benjamin; Gregory L Kearns; Michael Cohen-Wolkowiez
Journal:  J Clin Pharmacol       Date:  2016-08-23       Impact factor: 2.860

Review 8.  Regulation of Human Cytochrome P4501A1 (hCYP1A1): A Plausible Target for Chemoprevention?

Authors:  Rebeca Santes-Palacios; Diego Ornelas-Ayala; Noel Cabañas; Ana Marroquín-Pérez; Alexis Hernández-Magaña; Sitlali Del Rosario Olguín-Reyes; Rafael Camacho-Carranza; Jesús Javier Espinosa-Aguirre
Journal:  Biomed Res Int       Date:  2016-12-26       Impact factor: 3.411

Review 9.  Physiology and Pathophysiology of Steroid Biosynthesis, Transport and Metabolism in the Human Placenta.

Authors:  Waranya Chatuphonprasert; Kanokwan Jarukamjorn; Isabella Ellinger
Journal:  Front Pharmacol       Date:  2018-09-12       Impact factor: 5.810

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.